SREC for Nicotine Addiction (NIDA-SREC Trial)

"This clinical trial is only open to patients between 21 and 70 years old. For those younger than 18 or older than 65, there are 7 trials available for the former age group and 138 trails offered for the latter."

"This two-year clinical trial has the primary goal of measuring changes in mean scores on the Questionnaire for Smoking Urges (QSU-Brief). Other objectives include comparing the specificity of anabasine or nicotelline to nicotine metabolites and analysing levels of exposure to tobacco smoke toxins between dual SREC-TC use and TC-only use. Lastly, researchers will compare changes in blood pressure between SREC-only and TC-only usage."

"A total of 20 nicotine-dependent adults, aged between 21 and 70, are able to join this trial. Additionally, they must possess a heart rate lower than 105 beats per minute, systolic blood pressure below 160 and above 90 as well as diastolic blood pressure no greater than 100 but at least 50. The BMI should not exceed 38.0 while the carbon dioxide level in their expired air is 5ppm or higher. Applicants also need to have been dual users (both electronic cigarettes and tobacco cigarettes) for at least 10 days prior within the last month's time with an inclination towards nonmenthol flavored e-cigarettes"

"Yes, the clinical trial is still active and enrolling. According to the data posted on clinicaltrials.gov, it was initially released in August 1st 2022 and has been updated as recently as August 24th of that same year. The study requires 20 individuals from two separate medical sites for its completion."

"Affirmative. The information provided on clinicaltrials.gov confirms that recruitment for this medical trial, which was first publicised on August 1st 2022, is currently underway. Approximately 20 patients are being sought from two separate sites."